Research output per year
Research output per year
Fingerprint
Dive into the research topics where borne & STIs (inc. HIV and Hepatitis) is active. These topic labels come from the works of this organisation's members. Together they form a unique fingerprint.
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Profiles
Research output
-
Adapting the Flexible Farrington Algorithm for daily situational awareness and alert system to support public health decision-making during the SARS-CoV-2 epidemic in England
Simms, I., Charlett, A., Colón-González, F. J., Blomquist, P. B., Lake, I. R., Zaidi, A., Shadwell, S., Sedgwick, J., Paranthaman, K. & Vivancos, R., 6 Feb 2025, In: Epidemiology and Infection. 153, e28.Research output: Contribution to journal › Article › peer-review
Open Access -
Assessing Whether Providing Regular, Free HIV Self-Testing Kits Reduces the Time to HIV Diagnosis: An Internet-Based, Randomized Controlled Trial in Men Who Have Sex With Men
Dunn, D. T., Mccabe, L., Ward, D., Phillips, A. N., Lampe, F. C., Burns, F., Delpech, V., Weatherburn, P., Charles Witzel, T., Pebody, R., Kirwan, P., Khawam, J., Croxford, S., Brady, M., Fenton, K. A., Trevelion, R., Collaco-Moraes, Y., Mccormack, S. & Rodger, A. J., 1 Mar 2025, In: Journal of Acquired Immune Deficiency Syndromes. 98, 3, p. 274-281 8 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Corrigendum to How has post-implementation surveillance of high-coverage vaccination with HPV16/18-AS04 vaccine in England added to evidence about its cross-protective effects? Vaccine. 2024 Oct 24;42(24):126215. doi: 10.1016/j.vaccine.2024.126215. Epub 2024 Aug 29. PMID: 39213982 (Vaccine (2024) 42(24), (S0264410X24008971), (10.1016/j.vaccine.2024.126215))
Navarro-Torné, A., Anderson, A., Panwar, K., Ghys, E., Benninghoff, B., Weynants, V., Beddows, S. & Checchi, M., 15 Feb 2025, In: Vaccine. 47, 126701.Research output: Contribution to journal › Comment/debate
Impacts
-
Assay development to detect ceftriaxone resistance markers in Neisseria gonorrhoeae from clinical specimens
Day, M. (Participant), Boampong, D. (Participant), Pitt, R. (Participant), Bari, A. (Participant), Rebec, M. (Participant), Saunders, J. (Participant), Fifer, H. (Participant), Mbisa, J. L. (Participant) & Cole, M. J. (Participant)
Impact: Health impacts
-
A unique HCV whole genome sequencing service supporting UK and WHO HCV elimination goals
Bradshaw, D. (Participant) & Mbisa, T. (Participant)
Impact: Health impacts
-
Evaluation of Opt-out Bloodborne Virus Testing in Emergency Departments
Roche, R. (Participant)
Impact: Health impacts